Quote:
"It’s pretty clear to some. They said they field for EUA. The title is different because the title included all countries which are not created equal. As in Brazil we didn’t file anything yet."

Here's the title from PR:
"CytoDyn to Hold Webcast on March 22 to Provide an Update on COVID-19 Initiatives and Expected Regulatory Filings with the U.S., U.K., Canada, Philippines and Brazil"

Here is my rewrite:
CytoDyn to Hold Webcast on March 22 to Provide an Update on COVID-19 Initiatives and on Regulatory Filings with the U.S., U.K., Canada, and Expected Regulatory Filings with the Philippines and Brazil.

If it was pretty clear we wouldn't have spent most of the morning debating. What I believe is clear is how simple it would have been to get it right. I did it without any stock options, or annual salary involved for motivation. We've got a bunch of MDs and PhDs in the group. How tough can it be?

That said, I see this as very good news. However, filing for an EUA is not receiving an EUA. Filing is making very little difference in share price. Receiving an approval from any, or all, of the three we filed with should be a very nice catalyst for SP and would likely bring the same from the other two. Hope is nice, but reality is what makes the real difference. This stock has been running on hope for a long time. Let's get some reality working for us. Hopefully that happens from these direct efforts. <grin>